Your browser is no longer supported. Please, upgrade your browser.
NVAX Novavax, Inc. daily Stock Chart
Novavax, Inc.
Index- P/E- EPS (ttm)-4.14 Insider Own0.10% Shs Outstand44.42M Perf Week-8.05%
Market Cap2.90B Forward P/E10.00 EPS next Y4.60 Insider Trans-15.69% Shs Float57.75M Perf Month150.08%
Income-115.30M PEG- EPS next Q-0.55 Inst Own23.10% Short Float9.89% Perf Quarter187.75%
Sales18.10M P/S160.10 EPS this Y44.90% Inst Trans81.87% Short Ratio0.57 Perf Half Y1127.73%
Book/sh-0.54 P/B- EPS next Y10.10% ROA-53.90% Target Price23.17 Perf Year703.49%
Cash/sh3.77 P/C12.21 EPS next 5Y0.00% ROE78.80% 52W Range3.54 - 61.50 Perf YTD1056.78%
Dividend- P/FCF- EPS past 5Y5.60% ROI- 52W High-25.14% Beta0.92
Dividend %- Quick Ratio13.40 Sales past 5Y-9.50% Gross Margin- 52W Low1200.57% ATR5.19
Employees165 Current Ratio13.40 Sales Q/Q-15.00% Oper. Margin- RSI (14)64.71 Volatility11.00% 13.05%
OptionableYes Debt/Eq- EPS Q/Q72.50% Profit Margin- Rel Volume0.41 Prev Close44.84
ShortableYes LT Debt/Eq- EarningsMay 11 AMC Payout- Avg Volume10.02M Price46.04
Recom2.10 SMA2029.59% SMA5092.15% SMA200340.84% Volume4,072,541 Change2.68%
May-28-20Reiterated B. Riley FBR Buy $53 → $61
May-12-20Reiterated H.C. Wainwright Buy $33 → $50
Apr-30-20Reiterated H.C. Wainwright Buy $24 → $33
Nov-27-19Resumed B. Riley FBR Buy $12
Aug-14-19Reiterated H.C. Wainwright Buy $10 → $17
Feb-28-19Downgrade Piper Jaffray Overweight → Underweight $4.50 → $0.25
Dec-18-18Initiated Ladenburg Thalmann Buy $3
Dec-11-18Initiated Oppenheimer Outperform $4
Nov-26-18Upgrade Piper Jaffray Neutral → Overweight
Sep-21-18Upgrade JP Morgan Underweight → Overweight
Mar-29-18Upgrade Seaport Global Securities Neutral → Buy $5
Mar-19-18Downgrade JP Morgan Neutral → Underweight
Mar-01-18Upgrade Citigroup Neutral → Buy
Jan-05-18Initiated B. Riley FBR, Inc. Buy $2.25
Dec-19-17Downgrade Citigroup Buy → Neutral
Oct-31-17Upgrade Citigroup Neutral → Buy
Aug-09-17Upgrade Ladenburg Thalmann Neutral → Buy
Sep-20-16Reiterated Chardan Capital Markets Neutral $5.75 → $1.50
Sep-16-16Reiterated FBR & Co. Outperform $17 → $12
Sep-16-16Downgrade Wedbush Outperform → Neutral $14 → $2
May-29-20 01:38PM  Top Small Cap Stocks for June 2020 Investopedia
07:54AM  Edited Transcript of NVAX earnings conference call or presentation 11-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-28-20 07:11PM  Novavax (NVAX) Stock Is a Winner, but How Much Higher Can It Go? TipRanks
01:20PM  How Novavax is pulling out all the stops to produce a coronavirus vaccine by next year Yahoo Finance
11:34AM  ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic' Yahoo Finance
07:01AM  Coronavirus 2020: Where to Invest $500 Right Now Motley Fool
02:16AM  Novavax Seeks To Make 1 Billion Covid-19 Vaccine Doses; Top Analyst Ramps Up PT To $61 SmarterAnalyst
May-27-20 04:37PM  Covid Report: Why Moderna's Vaccine Prodded A Mass Biotech Sell-Off Investor's Business Daily -5.62%
03:44PM  Novavax Makes a $167 Million Purchase to Boost Its Coronavirus Vaccine Production Capacity Motley Fool
03:38PM  Coronavirus latest: Wednesday, May 27 Yahoo Finance Video
12:31PM  Biotech ETFs Soaring on COVID-19 Vaccine Progress Zacks
11:39AM  The Zacks Analyst Blog Highlights: Novavax, Moderna, Pfizer, Gilead and Vir Biotechnology Zacks
11:30AM  S&P Reclaims 3,000 Mark: Go Long With These ETFs Zacks
11:15AM  Novavax aims to make 1 billion COVID-19 vaccine doses after buying plant Reuters
10:49AM  Stock Market News for May 27, 2020 Zacks
10:08AM  Biotech Stock Roundup: REGN's Stake Buyback, INO, NVAX's Coronavirus Updates & More Zacks
08:22AM  Novavax buys Praha Vaccines for $167 mln to boost COVID-19 vaccine production Reuters
08:00AM  Novavax Expands Large-Scale Global Manufacturing Capacity GlobeNewswire
May-26-20 05:02PM  The Dow Rose 530 Points Because a Coronavirus Vaccine Could Cure the Economy
04:58PM  Merck CEO Warns a Covid-19 Vaccine Could Take Longer Than 18 Months. Moderna Stock Tumbles.
04:42PM  Dow closes up 500 points, tests 25,000 level, on recovery hopes and vaccine news MarketWatch
04:34PM  Global Stocks Rally on Recovery Hopes and Vaccine News
04:30PM  US STOCKS-S&P 500 rises on economic recovery and vaccine hopes, pulls back from highs Reuters
04:13PM  Covid Report: Why Vaccine News Sent A Field Of Drugmakers Rising Investor's Business Daily
04:12PM  FOREX-Dollar weakens as investors' risk appetite ramps up Reuters
04:08PM  Dow closes 500 points higher as optimism builds for economic reopening MarketWatch
04:00PM  US STOCKS-S&P 500 rises on economic recovery and vaccine hopes, pulls back from highs Reuters
03:37PM  Novavax Analyst Sees Leading Contender In Coronavirus Vaccine Race Benzinga
02:47PM  Why Moderna Is Dropping Today Motley Fool
02:45PM  Coronavirus update: Global case tally crosses 5.5 million as WHO warns of risk of second peak in current infection wave MarketWatch
02:30PM  US STOCKS-S&P 500 clears 3,000 barrier on economic recovery and vaccine hopes Reuters
01:47PM  Coronavirus update: Novavax begins vaccine trials; Brazil reports second-highest number of cases in world Yahoo Finance
01:12PM  REFILE-US STOCKS-S&P 500 clears 3,000 barrier on hopes of recovery, vaccine Reuters
01:00PM  Dow Jones Surges 600 Points On Coronavirus Vaccine Hopes, But Cuts Gains; Alphabet, Apple Hit New Buy Points Investor's Business Daily
12:06PM  US STOCKS-S&P 500 tops 3,000 on hopes of economic recovery, COVID-19 vaccine Reuters
11:53AM  Novavax expects COVID-19 vaccine trial results in July Yahoo Finance
11:52AM  Novavax Stock Is Soaring. The Company Is Starting Covid-19 Vaccine Trials.
11:51AM  FOREX-Dollar dented as risk appetite ramps up Reuters
11:43AM  GE Is an Industrial Stock but a Covid-19 Vaccine Is the Remedy It Needs
11:15AM  Novavax: Price Over Earnings Overview Benzinga
10:48AM  US STOCKS-S&P 500 tops 3,000 pts on hopes of economic recovery, COVID-19 vaccine Reuters
10:29AM  Novavax Begins Early Stage Clinical Study of Its Coronavirus Vaccine Candidate Motley Fool
10:15AM  Pre-Markets Race Higher on Vaccine Hopes Zacks
10:10AM  BlackRock portfolio manager says stock investors should watch out for these blind spots right now MarketWatch
09:59AM  Novavax and Merck Fuel COVID-19 Vaccine Hopes Investopedia
09:54AM  Dow surges 600 points, S&P 500 punches above key technical level as stock-market investors focus on Novovax, Merck vaccine candidates MarketWatch
09:46AM  Economic Data Deluge Zacks
09:39AM  Coronavirus Vaccine Efforts Continue, Novavax Begins Human Trial Zacks
09:33AM  The Dow Is Rising Because Vaccines Are In the News Again
09:22AM  US STOCKS-Wall St set to surge at open on recovery, vaccine hopes Reuters
08:34AM  Why Novavax Stock Is Skyrocketing Today Motley Fool
08:17AM  2 Top Factors Buoy Wall Street Since Memorial Day: 5 Picks Zacks
08:00AM  Floor Traders Return to NYSE, Novavax Vaccine News, Be Amphibious
07:58AM  US STOCKS-S&P 500 futures surge on recovery, vaccine hopes Reuters
07:52AM  Coronavirus Vaccine Development Gathers Steam: 4 Winners Zacks
07:11AM  New York Stock Exchange, Novavax, Latam - 5 Things You Must Know Tuesday
05:40AM  Travel companies lead European stocks higher as global markets rally MarketWatch
05:22AM  Novavax Shares Rocket Higher As Biotech Starts Phase One COVID-19 Vaccine Trial
04:31AM  Novavax trials coronavirus vaccine candidate in Australia MarketWatch
02:48AM  Novavax Begins Phase 1 Clinical Trial Of Its Coronavirus Vaccine Benzinga
02:16AM  PRESS DIGEST- Wall Street Journal - May 26 Reuters
02:06AM  Novavax Begins Human Testing For Covid-19 Vaccine, Expects Results In July SmarterAnalyst
May-25-20 10:12PM  Novavax launches its first coronavirus vaccine test on humans Reuters
07:54PM  Australia to outline economic recovery plans as lockdowns ease Reuters
06:13PM  Stock market news live updates: Stock futures open higher, Dow futures gain 200+ points Yahoo Finance
04:30PM  Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine GlobeNewswire
04:30PM  Novavax starts Phase 1 clinical trial of coronavirus vaccine candidate Reuters
May-24-20 09:16AM  Does Novavax Have What It Takes to Win the COVID-19 Vaccine Race? Motley Fool
08:21AM  An 'unprecedented' effort to find a coronavirus vaccine has over 100 horses in the race Yahoo Finance
May-22-20 03:44PM  Novavax Hopes to Reverse Past Setbacks With Covid-19 Vaccine -7.91%
11:56AM  INSIGHT-How one Indian company could be world's door to a COVID-19 vaccine Reuters
May-21-20 03:48PM  Fmr. CDC Official: 'were not cutting any corners' on COVID-19 vaccine development Yahoo Finance Video -5.19%
May-20-20 08:14PM  Novavaxs COVID-19 Vaccine Candidate Could Be the One, Says Top Analyst TipRanks
07:08PM  Is Moderna Winning the COVID-19 Vaccine Race? ETFs to Gain Zacks
May-19-20 06:46PM  Has Novavax (NVAX) Stock Come Too Far, Too Fast? TipRanks -5.37%
03:18PM  Johns Hopkins doctor on Trump's preventative hydroxychloroquine use: 'hopefully other people will not follow this example' Yahoo Finance Video
04:18AM  Novavax Seeks To Raise $250 Million From Share Sale; Top Analyst Bumps Up PT SmarterAnalyst
May-18-20 05:28PM  Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry Insider Monkey +30.55%
03:10PM  10 Health and Pharmaceutical Companies Fighting the COVID-19 Coronavirus Kiplinger
02:54PM  We anticipate a U-Shaped to Swoosh-Shaped recovery: Strategist Yahoo Finance Video
02:47PM  Moderna COVID-19 vaccine data is baby-step in right direction: Expert Yahoo Finance Video
02:05PM  Heres what it will take for the stock market to hit a new record within 2 months MarketWatch
12:17PM  Why Novavax Is Blasting Higher Today Motley Fool
10:14AM  Novavax Shares Climb as B. Riley FBR Raises Price Target
10:03AM  3 ETFs in Focus as Race for Vaccine Intensifies Investopedia
08:35AM  Wining ETF Areas of Last Week Zacks
May-17-20 10:12AM  Bullish: Analysts Just Made A Huge Upgrade To Their Novavax, Inc. (NASDAQ:NVAX) Forecasts Simply Wall St.
May-16-20 08:08AM  Moderna and Novavax are Making Strides in Advancing Novel Coronavirus Vaccine Research Motley Fool
06:29AM  Where Will Novavax Be in 1 Year? Motley Fool
May-15-20 03:09PM  Trump unveils vaccine effort, says country will be back on its feet with or without one Yahoo Finance Video +13.92%
09:59AM  Novavax, Inc. (NASDAQ:NVAX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates Simply Wall St.
May-14-20 07:38PM  Novavax (NVAX): Next Stop, $150? TipRanks -5.83%
11:30AM  Is Novavax (NVAX) Stock Outpacing Its Medical Peers This Year? Zacks
May-13-20 10:18AM  Novovax (NVAX) Surges on CEPI Funding for Coronavirus Vaccine Zacks
07:55AM  Vaccine Maker Novavax Shares Have Soared but Can It Continue?
07:02AM  Is Novavax Stock Too Hot to Handle After Skyrocketing Over 900% This Year? Motley Fool
May-12-20 04:33PM  Novavax Stock Rockets On Funding Boost For Coronavirus Vaccine Investor's Business Daily +62.53%
04:07PM  Coronavirus latest: Tuesday, May 12 Yahoo Finance Video
02:56PM  Coronavirus update: U.S. death toll tops 81,000; Trump defends administrations record in testy exchange with reporters MarketWatch
02:08PM  Novavax Analysts Say CEPI Funding 'Speaks Volumes' About Coronavirus Vaccine Development Benzinga
Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company's lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate that in Phase III clinical trial to protect infants from RSV disease through maternal immunization; and NanoFlu, which is in Phase III clinical trial for treating seasonal influenza in older adults. Its lead adjuvant is Matrix-M that is used to enable a vaccine to enhance the amplitude of the immune response and qualitatively change it, and the immune systems attack against microorganisms, as well as to allow immunization with much lower doses of antigen. The company is also developing RSV F vaccine for older adults (60 years and older) that is in Phase II clinical trial, as well as for healthy children between six months to five years of age that is in Phase I clinical trial. In addition, it develops nanoparticle vaccine candidates for clinic testing against ebola virus that is in Phase I clinical trial; and combination respiratory vaccine to protect against influenza and RSV. Further, the company is developing COVID-19 vaccine for coronavirus that causes pneumonia-like symptoms, which is in preclinical stage. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Herrmann John A IIISVP, General CounselMay 18Option Exercise26.1912,961339,4487,774May 20 04:35 PM
Herrmann John A IIISVP, General CounselMay 18Sale49.4412,961640,792275May 20 04:35 PM
Glenn Gregory MPresident, R&DJan 31Buy3.861,2504,8251,373Feb 04 05:11 PM
MCMANUS MICHAEL A JRDirectorNov 18Sale3.823,92915,0159,951Nov 20 04:17 PM
Herrmann John A IIISVP, General CounselSep 17Sale7.073,64325,7570Sep 18 04:14 PM
Glenn Gregory MPresident, R&DSep 13Sale6.189,62059,476123Sep 16 04:18 PM
Trizzino JohnSVP, CBO and CFOSep 11Sale5.725,57831,9114,800Sep 12 04:29 PM